Mirum Pharmaceuticals, Inc. reports

Company location: Foster City, CA
Fiscal year end: 31 December

Mirum Pharmaceuticals, Inc. has filed 643 SEC EDGAR filings since 20 Nov 2018

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 301-325 of 643 matching filings.

Per page

25

Current page

13

8-K File 001-38981

8-K

Filing date: 05 Sep 2023
Reporting date: 31 Aug 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38981

8-K

Filing date: 30 Aug 2023
Reporting date: 24 Aug 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Aug 2023
Reporting date: 25 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-38981

10-Q

Filing date: 07 Aug 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38981

MIRUM PHARMACEUTICALS, INC. 8-K

Filing date: 03 Aug 2023
Reporting date: 03 Aug 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38981

8-K

Filing date: 17 Jul 2023
Reporting date: 16 Jul 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jul 2023
Reporting date: 03 Jul 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jul 2023
Reporting date: 03 Jul 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jul 2023
Reporting date: 03 Jul 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jul 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 05 Jul 2023
Reporting date: 03 Jul 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-91075

NEW ENTERPRISE ASSOCIATES 16, L.P. / MIRUM PHARMACEUTICALS, INC. -- SCHEDULE 13D

Filing date: 23 Jun 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Jun 2023
Reporting date: 13 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Jun 2023
Reporting date: 13 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Jun 2023
Reporting date: 13 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Jun 2023
Reporting date: 13 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Jun 2023
Reporting date: 13 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Jun 2023
Reporting date: 13 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Jun 2023
Reporting date: 13 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Jun 2023
Reporting date: 13 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Jun 2023
Reporting date: 13 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 14 Jun 2023
Reporting date: 12 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 14 Jun 2023
Reporting date: 12 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 14 Jun 2023
Reporting date: 12 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 14 Jun 2023
Reporting date: 12 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .